PSPN
Processa hires Flesher as Chief Operating Officer
Processa Pharmaceuticals named Gregory J. Flesher as its new Chief Operating Officer, effective November 2, 2026. He will receive a $700,000 annual base salary and be eligible for a discretionary performance bonus of up to 60%.